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doses of radiation in large areas, including the oral mucosa, may result in several undesired 
reactions that manifest during or after the completion of therapy. The multidisciplinary 
management is the best alternative to minimize or even prevent such reactions, and the 
										
				
to the main oral sequelae from head and neck radiotherapy and establishes clinical oral 
management protocol for these irradiated patients.
Key-words: Radiotherapy. Radiation effects. Head and neck neoplasms. Mucositis. 
Osteoradionecrosis. Xerostomia.
INTRODUCTION
	 		 	 	 	
population, it is reasonable to expect that more 
								
head and neck cancer.
!						
or chemotherapy, has produced a significant 
increase in cure rates for many malignancies of 
the head and neck region23	
				
radiation in large areas, including the oral mucosa, 
skin, maxilla, mandible and salivary glands may 
result in several undesired reactions that manifest 
during or after the completion of therapy. This 
damage is caused by the ionizing radiation in normal 
					27.
Mucositis, candidosis, dysgeusia, radiation 
caries, osteoradionecrosis, soft tissue necrosis, 
progressive periodontal attachment loss, trismus 
and xerostomia are some of radiotherapy’s 
complications, significantly affecting patients’ 
quality of life.
Implementation of oral care protocols before and 
after radiation therapy and frequent assessment 
of lesions during therapy can prevent or, at least, 
decrease the incidence and severity of these 
complications. The literature is confusing about the 
establishment of a clinical care guideline. Therefore, 
this paper discusses the main adverse effects of 
head and neck radiotherapy and proposes a clinical 
oral management protocol for patients undergoing 
this treatment.
LITERATURE REVIEW
Radiation-induced changes can be divided 
										
occurrence: early or acute side effects that are noted 
during or immediately after treatment; and late side 
effects that develop months or years after the end 
of radiation therapy23. The degree, progression and 
no reversibility of these changes are related to the 
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								
hypovascularity and hypocellularity of tissues, the 
age at diagnosis and the healing capacity of the 
exposed epithelial cells6,25. There are many oral 




Mucositis is the most common acute side effect 
experienced by patients undergoing head and neck 
radiotherapy23. In almost all cases the patients 
	 #				
	 	 	 	 10. Mucosal damage 
	 	 	 	 	 	 	 	
	 	 	 	 	 	




field involves the pharyngeal mucosa, it may 
					
Clinically, mucositis is characterized by 








and changing salivary composition7. As a result, the 
sensation of oral dryness (xerostomia) occurs early 
during the irradiation treatment1. The duration of 
depressed salivary function varies among patients. 
Recovery of adequate saliva may be gradual 
over several months or may result in permanent 
glandular changes that cause irreversible loss of 
ability to secrete saliva16,19. The extent of radiation-
induced salivary dysfunction depends on the dose of 
radiation, the volume of irradiated gland tissue and 
the nature of the salivary glands being irradiated18.
The functional impairment of salivary glands results 
in impeded oral functioning, a burning sensation, 
cracked lips, and increased susceptibility to oral 
infections and dental caries10,33. Radiation therapy 
also changes the composition of saliva, increasing 
its viscosity, reducing its buffering capacity, 
altering its concentration of electrolytes, and 
changing its nonimmune and immune antibacterial 
systems10,19,33.
Radiation caries
Changes in the chemical composition of saliva 
and increased amounts of cariogenic oral bacteria 
	 	 	 	 	 	 	
Radiation caries is not caused directly by irradiation, 
but results from the sequelae of xerostomia: 
decrease of pH, reduced buffering capacity, and 
increased viscosity23. Clinically it has a rampant 
form, and tends to spread to all dental surfaces, 
changing their translucency and color. The carious 
process can cause increased friability and the 
	 	 	 	 	 	 	 	
	 	 	 	 	
oclusal, incisal and palatal surfaces35.
Craniofacial disturbances
The craniofacial disturbances are those that 
	 	 	 	 	 	 	
								
disturbances in the craniofacial region, if it is 
	 	 	 		 	 	 	
being formed.
Abnormally small teeth (microdontia), short 
	 	 	 	 	 	
	 	 	 	 	
(taurodontism), premature closure of apices and 
delayed or arrested development of teeth have 
been reported7,22,24. The occurrence of these 
								
malocclusion and may adversely affect facial 
development23. Children undergoing radiation 
therapy may experience abnormalities in the 
	 	 	 	 	 	
structures4,26. Craniofacial and dental abnormalities 
can cause severe cosmetic or functional sequelae, 
necessitating surgical or orthodontic intervention.
Osteoradionecrosis
One of the most severe adverse effects of 
				#	
condition resultant of the bone ionizing radiation. 
This radiation results in irreversible damages to the 
			
				
progressive decrease of the microvascularization. 
The tissue becomes hypovascular, hypocellular 
and hypoxic. All these features avoid the bone 
										
	 	 	 	 	 	 	
from injury to the remodeling system (osteocytes, 
osteoblasts and osteoclasts), causing atrophy, 
osteoradionecrosis and pathological fractures13,33. 
Tooth extraction and dental disease in irradiated 
regions have long been recognized as major risk 
factors for the development of osteoradionecrosis13. 
The mandible is much more susceptible to 
osteoradionecrosis than the maxilla, because its 
vascularization is poor and bone density is high. 
	
							
	 	!	 	 	 *	
					+18.
Clinical manifestations of osteoradionecrosis may 
	 	 	 	 	 	
bone, pathologic fracture and suppuration10. The 
patient may presents clinical signs and symptoms 
	 	 	 	 	 	 	 	
exposure of necrotic bone for longer than 3 months. 
Radiographically, irregular bone destruction is 
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observed and the mandible is most frequently 
involved (Figure 2). Associated symptoms of pain, 
trismus, and suppuration in the area of the lesion 
may also be present. The progression of this process 
can lead to pathologic fracture and intraoral and/
		11.
Trismus
Chronic reduction in oral opening is relatively 
uncommon in the general population but may be 
								
	
undergone treatment for an oral cancer by surgery, 
radiotherapy, chemotherapy or combinations of 
these.
	 	 	 	 	
hypomobility due to the radiotherapy develops, 
								
severity, and extent, are poorly understood. Its 






and extension. Usually temporomandibular joint 
hypomobility is regarded as a late effect of high 
		=					>?		
can be considered as trismus22 (Figure 3).
DISCUSSION AND MANAGEMENT 
PROTOCOLS
Radiotherapy is a treatment modality largely 
used for head and neck malignancies and although 
presents a significant increase in cure rates, 
	 	 	 	 	 
	 	 	
oral complications. This therapy presents many 
Figure 1- A: Mucosal atrophy and ulceration with pseudomembrane in the lateral tongue border; B and C: Diffuse erythema 
and ulceration with pseudomembrane in the tongue and lip mucosa of a patient subjected to head and neck radiotherapy 
(photographs kindly provided by Dr. Juliana Bertoldi Franco)
Figure 2- A: Clinical aspect of bone exposure and necrosis in a patient with osteoradionecrosis after radiotherapy treatment 
(photograph kindly provided by Dr. Marcos Martins Curi). B: Panoramic radiograph showing irregular osteolytic areas in the 
mandible of a patient with osteoradionecrosis
Figure 3- Limited mouth opening in a woman subjected 
to radiotherapy after a nasopharyngeal carcinoma 8 years 
before
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challenges primarily because the head and neck 
region has many critical structures that can be 
damaged by tumor or treatment. Damage to these 
									
	 	 	 	 	 	




therapy, 77% to 100% have mild-to-severe 
radiation damage of soft tissues and bones24,26.
The major clinical problem for patients developing 
oral mucositis is pain. Its adverse consequences 
include a decreased ability to eat, speak and 
sleep. The loss of the integrity of the oral mucosa 
also predisposes patients to systemic infections 
	 	 	 	 
23. Current care 
						
	
and includes appropriate oral hygiene, dietary 
	 	 	 	 B	
attention should be given to plaque control and 
oral hygiene. The protocol adopted by our service 
		E23	$>??G'				
use of nonalcoholic antiplaque rinses (like isotonic 
saline or sodium bicarbonate solution) to maintain 
	 	 	 	 	 #	
We recommended the use of topical anesthetics 
for pain relief, such as 2% viscous lidocaine or 
tetracaine-chloride (hexomedine spray), unless 
the pain requires systemic analgesic drugs, such 
non-steroids or opioids. Antimicrobial agents 
must be considered for either fungal or bacterial 
infections10,17. In our opinion, the use of complete 
dentures in this period should be discontinued. 
The dentures should be cleaned and immersed 
in a 0.5% sodium hypochlorite solution for 30 
min. If necessary to substitute the dentures, it 
is recommendable to do it only at the end of the 
therapy. Indeed, a study of Sandoval, et al.29 (2003) 
		*						
							
oral mucositis, improving the quality of life during 
the oncologic treatment.
Rubira, et al.28 (2007) evaluated the oral 
sequelae of radiotherapy in patients treated 
	 	 	 	 	 	 	 	 	
main effect of radiotherapy in the head and neck 
			 		 	
	#		
Several moistening agents and saliva substitutes 
are recommended to relief the discomfort due 
to hyposalivation1	 <	 	 		 	
recommend increasing amounts of liquid ingested, 
use of artificial saliva, use of non-alcoholic 
		?&>J			+	
	 	 	 #	 	 	 
	
	 
	 <	 	 	 	 	
prescribe dribbling lemon or 2% citric acid in the 
tongue dorsum to stimulate salivation as long as 
the patient does not suffer from mucositis.
B						
	 	 	 	 	 $	
pilocarpine) temporarily protects salivary-gland cells 
from acute radiation damage, reducing symptoms 
of xerostomia and mucosal toxicity9,16. Johnson, et 
al.13 (1993) evaluated pilocarpine hydrochloride 
for the treatment of radiation-induced xerostomia 
	 	 	 	 	 	 	 
	 	
decrease in the production of saliva. Patients 
received either placebo or pilocarpine (5 mg or 10 










			 not correlate 
	 	 	 		  
improvements in the group receiving the 10-mg 
dose. The primary 
					
addition to other minor cholinergic effects. Six and 
*		 	 		 	 	N*	
and &?*	 	 
	 	 	
the study because of adverse effects. According 
							
	
effects related to pilocarpine.




they had experienced unacceptable adverse effects. 





64%. The author concluded that for Japanese, 
5 mg t.i.d. pilocarpine caused a high incidence 
		
		=	 			




of the several adverse effects of this medicament, 
		
					
#	 	 ZZ	 	 	
urinary frequency, vasodilatation and bradycardia. 
[	 	 	 	 	 	
asthma, hypersensitivity and ophthalmologic 
diseases (miosis). We only prescribe pilocarpine 
in cases of really severe hyposalivation (such as 

	#				?&	\]		
stimulus in patients refractory to other treatments), 
after medical examination and consent. In addition, 
	 		 	 	 	 	
induce xerostomia (e.g., anorectic, antiemetic, 
antihistaminic, antihypertensive and antidepressant 
agents) should be carefully considered.
Because of the hyposalivation, patients also 
could develop dysgeusia and deglutition disorders, 
	 #	 	 	 	 	 	
							
the establishment of opportunist infections, such as 
candidiasis, a common fungal infection caused by 
Candida albicans. Rubira, et al.28 (2007) found a 
Oral adverse effects of head and neck radiotherapy: literature review and suggestion of a clinical oral care guideline for irradiated patients
2011;19(5):448-54
J Appl Oral Sci. 452
					+	
of candidiasis and post radiotherapy time (39.3 
_	`??>w'	<							
of nystatin 100,000 IU/mL, in oral suspension, t.i.d, 
for 15 days. More severe cases require the use of 
				#Z	&N?		
					&		>			
The decision to extract tooth before or after 
radiotherapy has traditionally been based on clinical 
experience and empirically designed protocols. 
The literature data regarding dental evaluation 
and extraction are confusing and inconclusive, 
	 #	 	 	 	
extractions before and after radiation therapy, and 
the main cause of this decision is the possibility 
to develop osteoradionecrosis15. To minimize the 
risk of developing osteoradionecrosis, optimal 
precautions should be adopted. These include 
complete removal of the nonrestorable teeth as 
soon as possible to maximize the healing period. 
When osteoradionecrosis results in small lesions 
of the bone, daily saline irrigations and antibiotic 
coverage are recommended23. For advanced 
presentations of osteoradionecrosis (pathologic 
	 	 *	 
Z	 	
'			 		 	
vascularized-bone grafting become the standard 
	 	 <	 	 	 	 	
						
drugs may be promising31. Treatment of avascular 




of therapies that include antibiotics, 0.12% 
		+		
resection of the necrotic bone, and hyperbaric 
oxygen therapy2.
=	 	 	 	 	 	
extractions before radiotherapy is the time interval 
				 			
								




time should not be extended a long period that 
could compromise the oncologic treatment and 
prognosis15.
B	 	 
	 	 	 	 	 	
hyperbaric oxygen resulted in improved local 
control and survival of the irradiated patients11,34. 
The hyperbaric oxygen therapy is one option to 
							
the adverse effects of some medicaments.
The prevalence of post-radiotherapy mandibular 
					
		NJ	
and 38%30,32. The variable incidence of mandibular 
							
									
location of the tumor, the nature and extent of 
	 			 	 	 			
combined surgery and adjunctive radiotherapy, and 
the level of movements performed by the patient 
	 	 	 	 	 	
Similarly, individual patient variation may have an 
effect, including advanced age, obesity, reduced 
tissue vascularity and other co-morbidities, such 




in head and neck oncology described the effects 
of therapeutic interventions as being scarcely 
investigated5. 
 
Although many of the interventions 
described have some rationale, there is little, if any, 
high quality evidence to support them. Treatment 
therefore tends to be pragmatic and empirical, and 
									
of the hypomobility. Some of the usually instituted 
treatments include physical and thermal therapies, 
massage, dietary advice, mandibular opening 
devices and simple exercises, electrotherapy, 
surgery and drugs8. We refer our patients to 
							
cited above.
The management of irradiated patients is a 
challenge to the dentist. Most of the clinicians 
	 	 	 	 	 	 
	 	 	
patients. There is no consensus in the literature 
about a standard oral attendance protocol to 
prevent and treat the patients in these cases. For 
					
			
considering the absence of an established protocol 
of intervention of head and neck irradiated patients, 
									
patients (Figure 4). Preferably, the patients should 
not undergo oral procedures during radiotherapy. 
These interventions should be done before or after 
the radiation treatment.
Oral procedures must be accomplished 20 to 30 
		 				 	 	
tissue repair and healing. After the radiotherapy 
treatment, the dentist can perform non-invasive 
procedures, such as small restorations; placement 
					}	_			
least 6 months should be have been elapsed to 
perform surgeries. The invasive procedures should 
be accomplished under prophylactic antibiotic 
therapy since the microvascularity of the bone is 
Figure 4- Suggestion of a clinical oral management protocol 







20 days 3 months
Invasive procedures 30 days 6 months*
* Prophylactic antibioticotherapy recommended 
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affected. We prescribe clindamycin-chloride 300 
mg 2 h before the procedure and clindamycin-
chloride 300 mg is maintained every 6 h for 7 
	!				
must be avoided for at least 12 months (Figure 4). 
Indeed, a multidisciplinary treatment, including 
physicians, dentists, speech therapy, nutritionists, 
and psychologists, is the best alternative to 
minimize or even prevent such reactions.
CONCLUSION
The oral management protocol of head and neck 




professionals. Early or late radiotherapy sequelae 
persist throughout years and the dentist should be 
					Z				
										
step in. It is evident that the most important aspect 
								
volume, modality, urgency, general state and 
				[			
that each case is particular and unique and that all 
factors already mentioned must be considered if 
the patient needs to undergo surgery.
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